A New Dawn in Cardio and Vascular Protection V. Cardiovascular High-Risk Patients: Treat to Protect
Cardiovascular and cerebrovascular diseases are a major cause of death and disability worldwide; around 7.1 million deaths, as well as two thirds of strokes and one half of ischemic heart disease, are attributable to nonoptimal blood pressure control. Large outcome trials have demonstrated that blockade of the renin-angiotensin system (RAS) is an important approach to […]
New Lifetime Risk Estimates Suggest 1 in 8 Baby Boomers Will Develop Alzheimer’s Disease
A new report released by the Alzheimer's Association includes new estimates that show the lifetime risk for Alzheimer's disease (AD) is 17% in women and 9% in men who live to age 55 years. The figures mean that 10 million of the 78 million baby boomers alive today can expect to develop AD in their […]
Quest Diagnostics Campaign Challenges Colorectal Cancer Screening Status Quo
'Do You Have the Guts?' aims to reach five million in five yearsMADISON, N.J., March 31, 2008 /PRNewswire-FirstCall via COMTEX News Network/ — Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing information and services, today announced the launch of a novel campaign designed to help increase compliance with take-home colorectal screening […]
Expert Viewpoint: William J. Gradishar, MD
Professor, Division of Hematology and Medical OncologyNorthwestern UniversityThe Feinberg School of MedicineChicago, IL William J. Gradishar, MD, is Professor of Medicine in the Division of Hematology and Medical Oncology at the Feinberg School of Medicine at Northwestern University in Chicago, Illinois, and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. […]
Risks of Transfusion
Bruce D. Spiess, MD, FAHAIntroductionBlood transfusion has evolved into a mainstay medical therapy. It has never undergone efficacy and safety testing the way in which a drug would be tested for approval by the US Food and Drug Administration.[1,2] Today, some 107 years after Karl Landsteiner discovered the ABO histocompatibility antigens, we are still learning […]
Patients With Alpha1-Antitrypsin Deficiency May Not Need Flu Vaccine
Despite guidelines that recommend influenza vaccination for patients with alpha1-antitrypsin deficiency (AATD), new research suggests that such vaccination has little impact on disease outcomes in those patients.
Noninvasive Positive Pressure Ventilation Improves Hypercapnia in Cystic Fibrosis
Nocturnal noninvasive positive pressure ventilation (NIV) reduces hypercapnia, improves symptoms, and increases exercise capacity in patients with cystic fibrosis (CF), according to a report in the January issue of Thorax.
A treatment strategy for NSCLC
Expert OpinionNasser Hanna, MDIndiana UniversityNasser Hanna, MD, is an assistant professor at Indiana University, medical director for their Thoracic Oncology Program, and chair of the thoracic committee for the Hoosier Oncology Group. Recently, WebMD spoke with Dr Hanna about the current treatment options in previously treated NSCLC, treatment decisions in this setting, and the role […]
International Health Regulations enter into force
New opportunity to respond to international public health threats 14 JUNE 2007 | GENEVA — The revised International Health Regulations (IHR) enter into force on Friday, 15 June. The Regulations consist of a comprehensive and tested set of rules and procedures which will help to make the world more secure from threats to global health. […]
RMGH NEWSLETTER
Guidelines for the Management of Post-MI Patients in the Outpatient SettingsRamaz Mitaishvili, MDGina Gagua, LAc, PhD Introduction Compelling clinical trial evidence exists that antiplatelet, ß-blocker, angiotensin-converting enzyme (ACE) inhibitor, and lipid-lowering therapies reduce the risk of recurrent cardiovascular events, hospitalization, and heart failure and substantially improve survival in Post MI patients. Despite this evidence as […]
